Remove FDA Remove Pharma Remove Prescription
article thumbnail

Dear FDA: WTF?

World of DTC Marketing

SUMMARY: The FDA wants to look at how certain brand names affect consumer and health care providers’ perceptions about the efficacy and the medical conditions for which they’re indicated. This is just another example of how clueless the FDA is regarding patient behavior and prescription drugs. The post Dear FDA: WTF?

FDA 180
article thumbnail

The debate on DTC marketing is going to heat up again

World of DTC Marketing

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The FDA needs to study what people do when they see a DTC ad. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. DTC ads raise awareness around health conditions.

Marketing 285
article thumbnail

FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date

Fierce Pharma

About a month after Eisai initiated a rolling FDA application for its subcutaneous form of Leqembi, the U.S. The FDA assigned the subcutaneous Leqembi application a Prescription Drug User Fee Act decision date of January 25, 2025. agency has accepted the filing. |

FDA 167
article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. Biogen’s failure should be a warning to other pharma companies. It should be a warning to other pharma companies. Now Biogen is a shell of a company selling off assets to survive.

Pharma 210
article thumbnail

Another reason change is needed at FDA? Fair balance

World of DTC Marketing

Pharma TV ads drive people online to search for more information. Safety pages on Pharma product websites continue to have high utility. As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. Prescription drugs are not the same as items found in a grocery store.

FDA 165
article thumbnail

AbbVie continues to be what’s wrong with big pharma

World of DTC Marketing

I continue to believe that there are very good people who care about patients working within pharma but it’s hard to understand how anyone who works for AbbVie can feel good about their employer. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S.

Pharma 202
article thumbnail

DTC marketing is an oxymoron

World of DTC Marketing

A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists side effects like cancer. For most a content strategy is unheard of and even though email marketing is still a very viable tactic pharma sees it as too complicated to measure the ROI.

Marketing 265